JMV 176

• Description :

  Jmv 176 is a CCK agonist when first given and becomes a cholecystokinin antagonist after 3-4 hours[1].

• UNSPSC :

  12352209

• Target :

  Cholecystokinin Receptor

• Type :

  Peptides

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/jmv-176.html

• Smiles :

  O=C(NC(CC1=CC=C(C=C1)OS(=O)(O)=O)C(NC(CCCC)C(CCC(NC(CC2=CNC3=C2C=CC=C3)C(NC(CCCC)C(NC(CC(O)=O)C(NC(CC4=CC=CC=C4)C(N)=O)=O)=O)=O)=O)=O)=O)OC(C)(C)C

• Molecular Formula :

  C53H70N8O15S

• Molecular Weight :

  1091.23

• References & Citations :

  [1]Gourch A, et al. A cholecystokinin agonist/antagonist according to dose and time of action: effect on food intake. Neuropeptides. 1990 Dec;17 (4) :187-91.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [119068-32-5]